SLN124

· Silence Therapeutics plc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SLN124, covering 2025-12-19 to 2025-12-19. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess SLN124 in Patients With Polycythemia Vera [Phase 1, Phase 2]